Citation and link to original article
- Wells J, Wang C, Dolgin K, Kayyali R. SPUR: A Patient-Reported Medication Adherence Model as a Predictor of Admission and Early Readmission in Patients Living with Type 2 Diabetes. Patient Prefer Adherence. 2023 Feb 19;17:441-455.
- https://doi.org/10.2147/ppa.s397424
Purpose: Poor medication adherence (MA) is linked to an increased likelihood of hospital admission. Early interventions to address MA may reduce this risk and associated health-care costs. This study aimed to evaluate a holistic Patient Reported Outcome Measure (PROM) of MA, known as SPUR, as a predictor of general admission and early readmission in patients living with Type 2 Diabetes.
Patients and Methods: An observational study design was used to assess data collected over a 12-month period including 6-month retrospective and 6-month prospective monitoring of the number of admissions and early readmissions (admissions occurring within 30 days of discharge) across the cohort. Patients (n = 200) were recruited from a large South London NHS Trust. Covariates of interest included: age, ethnicity, gender, level of education, income, the number of medicines and medical conditions, and a Covid-19 diagnosis. A Poisson or negative binomial model was employed for count outcomes, with the exponentiated coefficient indicating incident ratios (IR) [95% CI]. For binary outcomes (Coefficient, [95% CI]), a logistic regression model was developed.
Results: Higher SPUR scores (increased adherence) were significantly associated with a lower number of admissions (IR = 0.98,[0.96, 1.00]). The number of medical conditions (IR = 1.07, [1.01, 1.13]), age ≥80 years (IR = 5.18, [1.01, 26.55]), a positive Covid-19 diagnosis during follow-up (IR = 1.83, [1.11, 3.02]) and GCSE education (IR = 2.11, [1.15,3.87]) were factors associated with a greater risk of admission. When modelled as a binary variable, only the SPUR score (−0.051, [−0.094, −0.007]) was significantly predictive of an early readmission, with patients reporting higher SPUR scores being less likely to experience an early readmission.
Conclusion: Higher levels of MA, as determined by SPUR, were significantly associated with a lower risk of general admissions and
early readmissions among patients living with Type 2 Diabetes.
Download the poster - SPUR and prediction of hospital admission in DT2
We are processing this data per your request only. We are hosting the data internally. We will not share it. This information will be used to send you information from the author's team, and you will not subscribed to any newsletters other marketing materials. We store the data for maximum of 3 years on secure servers. You can find out how to send a request to access your data, request to delete your data, correct any inaccuracies or restrict our processing of your data. You have the right to lodge a complaint about the way we handle your data with French Data Protection authority CNIL or you can contact our DPO at This email address is being protected from spambots. You need JavaScript enabled to view it. for more information or with concerns. Please view our privacy policy. Subscribe to our newsletter.